Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen A Smythe

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The Annals of Pharmacotherapy|March 8, 2007
Advances in anticoagulation management: the role of pharmacyMaureen A Smythe
The New England Journal of Medicine|July 15, 2011
Dalteparin in critically ill patientsMaureen A Smythe, John M Koerber
The Annals of Pharmacotherapy|August 28, 2002
Comment: treatment of heparin-induced thrombocytopeniaMaureen A Smythe, Theodore E Warkentin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2016
Reversal agents for use with direct and indirect anticoagulantsMaureen A Smythe, Toby Trujillo, John Fanikos
Pharmacotherapy|September 23, 2023
Anticoagulant drug-drug interactions with cannabinoids: A systematic reviewMaureen A Smythe, Wendy Wu, Candice L Garwood
American Journal of Pharmaceutical Education|March 26, 2011
An innovative elective course in anticoagulation managementCandice L Garwood, Mirjon Bishja, Maureen A Smythe
Pharmacotherapy|February 26, 2010
Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literatureApril E Myzienski, Mark F Lutz, Maureen A Smythe
Pharmacotherapy|November 30, 2011
Strategies for managing heparin therapy in patients with antiphospholipid antibody syndromeTrupti P Mehta, Maureen A Smythe, Joan C Mattson
Annals of Emergency Medicine|March 30, 2005
Delayed-onset heparin-induced thrombocytopeniaMaureen A Smythe, Jennifer L Stephens, Joan C Mattson
Chest|April 3, 2007
The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospitalMaureen A Smythe, John M Koerber, Joan C Mattson
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|March 8, 2007
Advances in anticoagulation management: the role of pharmacyMaureen A Smythe
The New England Journal of Medicine|July 15, 2011
Dalteparin in critically ill patientsMaureen A Smythe, John M Koerber
The Annals of Pharmacotherapy|August 28, 2002
Comment: treatment of heparin-induced thrombocytopeniaMaureen A Smythe, Theodore E Warkentin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2016
Reversal agents for use with direct and indirect anticoagulantsMaureen A Smythe, Toby Trujillo, John Fanikos
Pharmacotherapy|September 23, 2023
Anticoagulant drug-drug interactions with cannabinoids: A systematic reviewMaureen A Smythe, Wendy Wu, Candice L Garwood
American Journal of Pharmaceutical Education|March 26, 2011
An innovative elective course in anticoagulation managementCandice L Garwood, Mirjon Bishja, Maureen A Smythe
Pharmacotherapy|February 26, 2010
Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literatureApril E Myzienski, Mark F Lutz, Maureen A Smythe
Pharmacotherapy|November 30, 2011
Strategies for managing heparin therapy in patients with antiphospholipid antibody syndromeTrupti P Mehta, Maureen A Smythe, Joan C Mattson
Annals of Emergency Medicine|March 30, 2005
Delayed-onset heparin-induced thrombocytopeniaMaureen A Smythe, Jennifer L Stephens, Joan C Mattson
Chest|April 3, 2007
The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospitalMaureen A Smythe, John M Koerber, Joan C Mattson
Pageof 5